16.21新台幣0.07(0.43%)
2021/02/24更新
績效 / 1月4.42%
3月12.65%
1年36.1%
晨星評等-
- 1.現金7.46%
- 2.股票45.51%
- 3.債券0.00%
- 4.其他47.03%
- 1.美國50.07%
- 2.新興亞洲18.27%
- 3.歐元區11.28%
- 4.歐洲不包含歐元區8.22%
- 5.日本6.28%
- 1.M3 Inc3.00%
- 2.WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S2.94%
- 3.BioXcel Therapeutics Inc2.40%
- 4.Teladoc Health Inc2.40%
- 5.Align Technology Inc2.38%
- 6.Hangzhou Tigermed Consulting Co Ltd Class A2.35%
- 7.Materialise NV ADR2.35%
- 8.NeoGenomics Inc2.31%
- 9.CRISPR Therapeutics AG2.30%
- 10.Guardant Health Inc2.22%
- 1.現金7.46%
- 2.股票45.51%
- 3.債券0.00%
- 4.其他47.03%
- 1.美國50.07%
- 2.新興亞洲18.27%
- 3.歐元區11.28%
- 4.歐洲不包含歐元區8.22%
- 5.日本6.28%
- 1.M3 Inc3.00%
- 2.WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S2.94%
- 3.BioXcel Therapeutics Inc2.40%
- 4.Teladoc Health Inc2.40%
- 5.Align Technology Inc2.38%
- 6.Hangzhou Tigermed Consulting Co Ltd Class A2.35%
- 7.Materialise NV ADR2.35%
- 8.NeoGenomics Inc2.31%
- 9.CRISPR Therapeutics AG2.30%
- 10.Guardant Health Inc2.22%